Dataset Information


IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen.

ABSTRACT: The autoantigen in Goodpasture disease is the noncollagenous domain of alpha3 type IV collagen [alpha3(IV)NC1]. We previously demonstrated that IL-12p40(-/-) mice are protected from experimental autoimmune anti-glomerular basement membrane (anti-GBM) glomerulonephritis, seemingly defining a role for IL-12 in this disease; however, the recent identification of IL-23, a heterodimer composed of IL-12p40 and IL-23p19 subunits, raises the possibility that IL-23, rather than IL-12, may modulate this disease instead. We immunized wild-type, IL-12p35(-/-) (IL-12 deficient, IL-23 intact), IL-12p40(-/-) (deficient in both IL-12 and IL-23), and IL-23p19(-/-) (IL-12 intact, IL-23 deficient) mice with recombinant mouse alpha3(IV)NC1. Wild-type mice developed autoreactivity to alpha3(IV)NC1: Humoral responses, cellular responses, renal histologic abnormalities, leukocyte accumulation, autoantibody deposition, and IL-17A mRNA expression (a cytokine produced by the IL-23-maintained Th17 subset). IL-23 but not IL-12 was detected in the immune system. Regardless of the presence of IL-12, mice deficient in IL-23 were protected, but mice with IL-23 were not. Both IL-23-deficient strains exhibited lower autoantibody titers, reduced cellular reactivity, diminished cytokine production (IFN-gamma [Th1], IL-17A [Th17], TNF, and monocyte chemoattractant protein 1), and less renal disease and glomerular IgG deposition. The deficient responses in the absence of IL-23 were not due to increased regulatory T cells; IL-12p40(-/-) and IL-23p19(-/-) mice did not show increased proportions of CD4(+)CD25(+)FoxP3(+) cells or IL-10 levels early in the immune response. In conclusion, autoreactivity to the Goodpasture antigen is directed primarily by IL-23, absence of which results in hyporeactivity including but extending beyond a deficient Th17 response.


PROVIDER: S-EPMC2678043 | BioStudies | 2009-01-01

REPOSITORIES: biostudies

Similar Datasets

2006-01-01 | S-EPMC1895704 | BioStudies
2019-01-01 | S-EPMC6639297 | BioStudies
2016-01-01 | S-EPMC6312101 | BioStudies
2016-01-01 | S-EPMC4891437 | BioStudies
2014-01-01 | S-EPMC3999171 | BioStudies
2018-01-01 | S-EPMC5773378 | BioStudies
2012-01-01 | S-EPMC3516683 | BioStudies
2015-01-01 | S-EPMC4467618 | BioStudies
2014-01-01 | S-EPMC4063408 | BioStudies
2019-07-23 | GSE123316 | GEO